Genomic landscapes by multiregion sequencing combined with circulation tumor DNA detection contribute to molecular diagnosis in glioblastomas
Figure 5.Comparison of EGFR mutations identified using ctDNA and tumor DNA sequencing. (A–C) Mutation hotspots of EGFR mutations present in the TCGA database, patient tissue WES data and ctDNA testing results.